Ignite Creation Date:
2024-05-06 @ 2:06 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04217954
Status:
COMPLETED
Last Update Posted:
2023-06-23
First Post:
2020-01-01
Brief Title:
HAIC With Oxaliplatin 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC
Sponsor:
Peking University
Organization:
Peking University
Organization Data
Organization:
Peking University
Class:
OTHER
Study ID:
FIBTC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University
Lead Sponsor Class:
OTHER
Responsible Party:
Xiaodong Wang MD
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University
Old Name:
None
Old Organization:
None